Q2 2021 Holdings
Filed 2021-08-16 | 86 holdings | $897.3M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Beam Therapeutics Inc(BEAM) | COM | 07373V105 | $264.2M | 2,052,506 | 29.4% |
| Argenx SE(ARGX) | SPONSORED ADR | 04016X101 | $237.9M | 790,282 | 26.5% |
| Celldex Therapeutics Inc New(CLDX) | COM NEW | 15117B202 | $100.7M | 3,012,081 | 11.2% |
| Annexon Inc(ANNX) | COM | 03589W102 | $77.1M | 3,425,038 | 8.6% |
| ALX Oncology Hldgs Inc(ALXO) | COM | 00166B105 | $50.0M | 914,035 | 5.6% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $40.1M | 108,374 | 4.5% |
| Avita Medical Inc(RCEL) | COM | 05380C102 | $29.0M | 1,411,117 | 3.2% |
| Ardelyx Inc(ARDX) | COM | 039697107 | $28.2M | 3,714,100 | 3.1% |
| Bioventus Inc(BVS) | COM CL A | 09075A108 | $26.2M | 1,486,956 | 2.9% |
| Alpha Teknova Inc(TKNO) | COM | 02080L102 | $17.2M | 725,000 | 1.9% |
| Cytosorbents Corp(CTSO) | COM NEW | 23283X206 | $9.8M | 1,304,369 | 1.1% |
| Cabaletta BIO Inc(CABA) | COM | 12674W109 | $6.0M | 696,378 | 0.7% |
| Atea Pharmaceuticals Inc(AVIR) | COM | 04683R106 | $5.1M | 237,360 | 0.6% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $1.1M | 12,957,222 | 0.1% |
| IGM Biosciences Inc(1K0) | COM | 449585108 | $285.0K | 3,425,455 | 0.0% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $200.5K | 20,799,303 | 0.0% |
| Allakos Inc(ALLKGUSD) | COM | 01671P100 | $189.3K | 2,216,996 | 0.0% |
| ADC Therapeutics SA(ADCT) | SHS | H0036K147 | $183.2K | 7,522,029 | 0.0% |
| Shattuck Labs Inc(STTK) | COM | 82024L103 | $162.9K | 5,619,914 | 0.0% |
| Replimune Group Inc(REPL) | COM | 76029N106 | $161.0K | 4,191,512 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $156.8K | 4,647,393 | 0.0% |
| Deciphera Pharmaceuticals in(DCPHEUR) | COM | 24344T101 | $155.4K | 4,244,721 | 0.0% |
| Jazz Pharmaceuticals PLC(JAZZ) | SHS USD | G50871105 | $152.8K | 860,101 | 0.0% |
| Medavail Holdings Inc | COM | 58406B103 | $143.6K | 11,724,726 | 0.0% |
| Krystal Biotech Inc(KRYS) | COM | 501147102 | $140.9K | 2,072,132 | 0.0% |
| OAK STR Health Inc(OSH3EUR) | COM | 67181A107 | $134.9K | 2,302,653 | 0.0% |
| Kymera Therapeutics Inc(KYMR) | COM | 501575104 | $122.8K | 2,531,508 | 0.0% |
| Seagen Inc(SGENUSD) | COM | 81181C104 | $121.8K | 771,385 | 0.0% |
| Verve Therapeutics Inc | COM | 92539P101 | $116.7K | 1,936,530 | 0.0% |
| The Beauty Health Company(SKIN) | COM CL A | 88331L108 | $106.7K | 6,353,246 | 0.0% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $100.3K | 6,449,577 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $98.6K | 594,732 | 0.0% |
| Dexcom Inc(DXCM) | COM | 252131107 | $98.4K | 230,558 | 0.0% |
| Livanova PLC(LIVN) | SHS | G5509L101 | $93.5K | 1,111,684 | 0.0% |
| Pliant Therapeutics Inc(PLRX) | COM | 729139105 | $91.9K | 3,156,401 | 0.0% |
| Nurix Therapeutics Inc(NRIX) | COM | 67080M103 | $84.6K | 3,190,077 | 0.0% |
| Regenxbio Inc(RGNX) | COM | 75901B107 | $83.1K | 2,138,201 | 0.0% |
| Stoke Therapeutics Inc(STOK) | COM | 86150R107 | $82.8K | 2,458,558 | 0.0% |
| Repare Therapeutics Inc(RPTX) | COM | 760273102 | $81.8K | 2,624,396 | 0.0% |
| Epizyme Inc(EPZMEUR) | COM | 29428V104 | $70.8K | 8,515,060 | 0.0% |
| Akero Therapeutics Inc(AKRO) | COM | 00973Y108 | $69.6K | 2,804,944 | 0.0% |
| Scholar Rock Hldg Corp(SRRK) | COM | 80706P103 | $66.7K | 2,307,028 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $62.5K | 1,215,657 | 0.0% |
| Zymergen Inc | COM | 98985X100 | $60.9K | 1,522,900 | 0.0% |
| Immunogen Inc(IMGNEUR) | COM | 45253H101 | $58.5K | 8,880,945 | 0.0% |
| 1Life Healthcare Inc | COM | 68269G107 | $55.1K | 1,666,963 | 0.0% |
| NGM Biopharmaceuticals Inc(NGMUSD) | COM | 62921N105 | $55.1K | 2,792,448 | 0.0% |
| Tcr2 Therapeutics Inc | COM | 87808K106 | $53.1K | 3,235,809 | 0.0% |
| Genmab A/S(GMAB) | SPONSORED ADS | 372303206 | $50.1K | 1,227,588 | 0.0% |
| Selectquote Inc(SLQT) | COM | 816307300 | $46.5K | 2,411,957 | 0.0% |